AI-generated analysis. Always verify with the original filing.
SciSparc Ltd. filed a Form 6-K current report on March 12, 2026, with no specific items disclosed.
Key Takeaways
1Report type: 6-K
2Filing date: 2026-03-12
3Items: N/A
Current Report Details
Event Type
Securities Issuance
Disclosure
Voluntary
Variant
6-K
Items Reported
6-K
Current Report on Form 6-K
Securities Issuance
$9459954.20B$2.5M$500.0K$1.5M
Exhibits (3)
6-K
REPORT OF FOREIGN PRIVATE ISSUER
99.1
PRESS RELEASE ISSUED BY SCISPARC LTD. TITLED "SCISPARC: SUBSIDIARY NEUROTHERA LABS (75%) SIGNS DEFINITIVE AGREEMENT TO ACQUIRE MAJORITY STAKE IN CLINIQUANTUM, INNOVATOR IN QUANTUM-BASED CLINICAL TRAILS."
99.2
PRESS RELEASE ISSUED BY SCISPARC LTD. TITLED "SCISPARC: NEUROTHERA LABS ANNOUNCES PUBLICATION OF INTERNATIONAL PATENT IN COLLABORATION WITH CLEARMIND MEDICINE FOR NOVEL THERAPY TARGETING WEIGHT LOSS AND FATTY LIVER DISEASE."